Work

Association of bone scan index (BSI) with prognostic biomarkers and survival in men with metastatic castration-resistant prostate cancer (mCRPC) enrolled in a prospective randomized controlled trial of tasquinimod.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.5081

Authors: Andrew J. Armstrong, Reza Kaboteh, Michael Anthony Carducci, Jan-Erik Damber, Walter Michael Stadler, Hansen Mats, Lars Edenbrandt, Goran Forsberg, Orjan Nordle, Roberto Pili, Michael J. Morris

Institutions: Duke Medical Center, Duke Cancer Institute, University of Gothenburg, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, University of Chicago, Active Biotech (Sweden), Roswell Park Comprehensive Cancer Center, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2602420633

Cites:

Cited by: 2

Related to: 10